161 related articles for article (PubMed ID: 31417180)
21. Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model.
Canale S; Cocco C; Frasson C; Seganfreddo E; Di Carlo E; Ognio E; Sorrentino C; Ribatti D; Zorzoli A; Basso G; Dufour C; Airoldi I
Leukemia; 2011 Dec; 25(12):1815-24. PubMed ID: 21701492
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes.
Meyer LK; Huang BJ; Delgado-Martin C; Roy RP; Hechmer A; Wandler AM; Vincent TL; Fortina P; Olshen AB; Wood BL; Horton TM; Shannon KM; Teachey DT; Hermiston ML
J Clin Invest; 2020 Feb; 130(2):863-876. PubMed ID: 31687977
[TBL] [Abstract][Full Text] [Related]
23. A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia.
Akkapeddi P; Fragoso R; Hixon JA; Ramalho AS; Oliveira ML; Carvalho T; Gloger A; Matasci M; Corzana F; Durum SK; Neri D; Bernardes GJL; Barata JT
Leukemia; 2019 Sep; 33(9):2155-2168. PubMed ID: 30850736
[TBL] [Abstract][Full Text] [Related]
24. Early pre-engraftment, functional, in vitro responsiveness of T lymphocytes in allotransplanted, acute leukemia patients: proliferation and release of a broad profile of cytokines, possibly predictive of graft-versus-host disease.
Liseth K; Sjo M; Paulsen K; Bruserud Ø; Ersvaer E
Eur Cytokine Netw; 2010 Mar; 21(1):40-9. PubMed ID: 20146989
[TBL] [Abstract][Full Text] [Related]
25. Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activity.
Gerby B; Armstrong F; de la Grange PB; Medyouf H; Calvo J; Verhoeyen E; Cosset FL; Bernstein I; Amselem S; Boissel N; Dombret H; Leblanc T; Baruchel A; Landman-Parker J; Ballerini P; Pflumio F
Leukemia; 2010 Mar; 24(3):646-9. PubMed ID: 19924146
[No Abstract] [Full Text] [Related]
26. Notch1 and IL-7 receptor signalling in early T-cell development and leukaemia.
González-García S; García-Peydró M; Alcain J; Toribio ML
Curr Top Microbiol Immunol; 2012; 360():47-73. PubMed ID: 22695916
[TBL] [Abstract][Full Text] [Related]
27. IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing.
Regis G; Icardi L; Conti L; Chiarle R; Piva R; Giovarelli M; Poli V; Novelli F
Leukemia; 2009 Nov; 23(11):2102-8. PubMed ID: 19626047
[TBL] [Abstract][Full Text] [Related]
28. CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.
Passaro D; Irigoyen M; Catherinet C; Gachet S; Da Costa De Jesus C; Lasgi C; Tran Quang C; Ghysdael J
Cancer Cell; 2015 Jun; 27(6):769-79. PubMed ID: 26058076
[TBL] [Abstract][Full Text] [Related]
29. The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL).
Gazi M; Moharram SA; Marhäll A; Kazi JU
Cancer Lett; 2017 Apr; 392():9-16. PubMed ID: 28159681
[TBL] [Abstract][Full Text] [Related]
30. p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.
Davies C; Hogarth LA; Mackenzie KL; Hall AG; Lock RB
Cell Cycle; 2015; 14(22):3602-12. PubMed ID: 26506264
[TBL] [Abstract][Full Text] [Related]
31. Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity.
Melão A; Spit M; Cardoso BA; Barata JT
Haematologica; 2016 Nov; 101(11):1368-1379. PubMed ID: 27470599
[TBL] [Abstract][Full Text] [Related]
32. Loss of miR-146b-5p promotes T cell acute lymphoblastic leukemia migration and invasion via the IL-17A pathway.
Tu Z; Xiong J; Xiao R; Shao L; Yang X; Zhou L; Yuan W; Wang M; Yin Q; Wu Y; Pan S; Leng J; Jiang D; He C; Zhang Q
J Cell Biochem; 2019 Apr; 120(4):5936-5948. PubMed ID: 30362152
[TBL] [Abstract][Full Text] [Related]
33. Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia.
Cox CV; Diamanti P; Moppett JP; Blair A
PLoS One; 2016; 11(10):e0165210. PubMed ID: 27764235
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy.
Ksionda O; Mues M; Wandler AM; Donker L; Tenhagen M; Jun J; Ducker GS; Matlawska-Wasowska K; Shannon K; Shokat KM; Roose JP
PLoS One; 2018; 13(5):e0193849. PubMed ID: 29799846
[TBL] [Abstract][Full Text] [Related]
35. Organ-specific microenvironment modifies diverse functional and phenotypic characteristics of leukemia-associated macrophages in mouse T cell acute lymphoblastic leukemia.
Chen SY; Yang X; Feng WL; Liao JF; Wang LN; Feng L; Lin YM; Ren Q; Zheng GG
J Immunol; 2015 Mar; 194(6):2919-29. PubMed ID: 25662994
[TBL] [Abstract][Full Text] [Related]
36. Rapid childhood T-ALL growth in xenograft models correlates with mature phenotype and NF-κB pathway activation but not with poor prognosis.
Poglio S; Cahu X; Uzan B; Besnard-Guérin C; Lapillonne H; Leblanc T; Baruchel A; Landman-Parker J; Petit A; Baleydier F; Amsellem S; Baud V; Ballerini P; Pflumio F
Leukemia; 2015 Apr; 29(4):977-80. PubMed ID: 25371179
[No Abstract] [Full Text] [Related]
37. IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.
Oliveira ML; Akkapeddi P; Ribeiro D; Melão A; Barata JT
Adv Biol Regul; 2019 Jan; 71():88-96. PubMed ID: 30249539
[TBL] [Abstract][Full Text] [Related]
38. Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia.
Cramer SD; Hixon JA; Andrews C; Porter RJ; Rodrigues GOL; Wu X; Back T; Czarra K; Michael H; Cam M; Chen J; Esposito D; Senkevitch E; Negi V; Aplan PD; Li W; Durum SK
Leukemia; 2018 Aug; 32(8):1795-1882. PubMed ID: 29535426
[No Abstract] [Full Text] [Related]
39. Calcineurin and GSK-3 inhibition sensitizes T-cell acute lymphoblastic leukemia cells to apoptosis through X-linked inhibitor of apoptosis protein degradation.
Tosello V; Bordin F; Yu J; Agnusdei V; Indraccolo S; Basso G; Amadori A; Piovan E
Leukemia; 2016 Apr; 30(4):812-22. PubMed ID: 26648536
[TBL] [Abstract][Full Text] [Related]
40. The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model.
García-Peydró M; Fuentes P; Mosquera M; García-León MJ; Alcain J; Rodríguez A; García de Miguel P; Menéndez P; Weijer K; Spits H; Scadden DT; Cuesta-Mateos C; Muñoz-Calleja C; Sánchez-Madrid F; Toribio ML
J Clin Invest; 2018 Jul; 128(7):2802-2818. PubMed ID: 29781813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
